# Tailored Treatment to Enhance Risk Perception in Sleep Apnea

> **NCT02314858** · NA · COMPLETED · sponsor: **National Jewish Health** · enrollment: 284 (actual)

## Conditions studied

- Obstructive Sleep Apnea (OSA)

## Interventions

- **BEHAVIORAL:** Brief Personalized Video (BPV)
- **BEHAVIORAL:** Non-Personalized Video (NPV)
- **BEHAVIORAL:** Treatment as Usual (TAU)

## Key facts

- **NCT ID:** NCT02314858
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-01
- **Primary completion:** 2020-04
- **Final completion:** 2021-03
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2021-06-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02314858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02314858, "Tailored Treatment to Enhance Risk Perception in Sleep Apnea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02314858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*